ondansetron has been researched along with Kidney Failure, Chronic in 6 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pregabalin is an effective alternative for treatment of uraemic pruritus." | 9.20 | Comparison of pregabalin with ondansetron in treatment of uraemic pruritus in dialysis patients: a prospective, randomized, double-blind study. ( Jiao, S; Meng, J; Ren, W; Xiao, Y; Yue, J; Zhao, T, 2015) |
| " We treated the pain of acute arthritis with the specific 5-hydroxytryptamine subtype 3 receptor antagonist ondansetron." | 7.69 | Treatment of acute gouty arthritis with the 5-hydroxytryptamine antagonist ondansetron. ( Ramadori, G; Schwörer, H, 1994) |
| "Pruritus is a common, unpleasant symptom of uremic patients." | 6.69 | Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. ( Balaskas, EV; Bamihas, GI; Karamouzis, M; Tourkantonis, A; Voyiatzis, G, 1998) |
| "Severe uraemic pruritus is rare, but distressing in children and can improve with ondansetron." | 5.32 | Ondansetron for paediatric uraemic pruritus: a case report. ( Deshpande, PV, 2004) |
| "During late 1991, a series of severe adverse events involving thrombocytopenia, renal insufficiency and thrombotic episodes was observed in patients receiving emetogenic chemotherapy." | 5.28 | Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetron. ( Childs, A; Coates, AS; Cox, K; Forsyth, C; Grygiel, JJ; Joshua, DE; McNeil, E, 1992) |
| "Pregabalin is an effective alternative for treatment of uraemic pruritus." | 5.20 | Comparison of pregabalin with ondansetron in treatment of uraemic pruritus in dialysis patients: a prospective, randomized, double-blind study. ( Jiao, S; Meng, J; Ren, W; Xiao, Y; Yue, J; Zhao, T, 2015) |
| " We treated the pain of acute arthritis with the specific 5-hydroxytryptamine subtype 3 receptor antagonist ondansetron." | 3.69 | Treatment of acute gouty arthritis with the 5-hydroxytryptamine antagonist ondansetron. ( Ramadori, G; Schwörer, H, 1994) |
| "Pruritus is a common, unpleasant symptom of uremic patients." | 2.69 | Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. ( Balaskas, EV; Bamihas, GI; Karamouzis, M; Tourkantonis, A; Voyiatzis, G, 1998) |
| "Severe uraemic pruritus is rare, but distressing in children and can improve with ondansetron." | 1.32 | Ondansetron for paediatric uraemic pruritus: a case report. ( Deshpande, PV, 2004) |
| "During late 1991, a series of severe adverse events involving thrombocytopenia, renal insufficiency and thrombotic episodes was observed in patients receiving emetogenic chemotherapy." | 1.28 | Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetron. ( Childs, A; Coates, AS; Cox, K; Forsyth, C; Grygiel, JJ; Joshua, DE; McNeil, E, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yue, J | 1 |
| Jiao, S | 1 |
| Xiao, Y | 1 |
| Ren, W | 1 |
| Zhao, T | 1 |
| Meng, J | 1 |
| Murphy, M | 1 |
| Reaich, D | 1 |
| Pai, P | 1 |
| Finn, P | 1 |
| Carmichael, AJ | 1 |
| Deshpande, PV | 1 |
| Schwörer, H | 1 |
| Ramadori, G | 1 |
| Balaskas, EV | 1 |
| Bamihas, GI | 1 |
| Karamouzis, M | 1 |
| Voyiatzis, G | 1 |
| Tourkantonis, A | 1 |
| Coates, AS | 1 |
| Childs, A | 1 |
| Cox, K | 1 |
| Forsyth, C | 1 |
| Joshua, DE | 1 |
| McNeil, E | 1 |
| Grygiel, JJ | 1 |
3 trials available for ondansetron and Kidney Failure, Chronic
| Article | Year |
|---|---|
Comparison of pregabalin with ondansetron in treatment of uraemic pruritus in dialysis patients: a prospective, randomized, double-blind study.
Topics: Adult; Aged; Analgesics; Antipruritics; Double-Blind Method; Drug Therapy, Combination; Female; gamm | 2015 |
A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch.
Topics: Antipruritics; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Onda | 2003 |
Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Female; Histamine; Humans; Kidney Failure, Chr | 1998 |
3 other studies available for ondansetron and Kidney Failure, Chronic
| Article | Year |
|---|---|
Ondansetron for paediatric uraemic pruritus: a case report.
Topics: Adolescent; Antipruritics; Female; Humans; Kidney Failure, Chronic; Ondansetron; Peritoneal Dialysis | 2004 |
Treatment of acute gouty arthritis with the 5-hydroxytryptamine antagonist ondansetron.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Colchicine; Contraindications; Eso | 1994 |
Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetron.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Female; Humans; Kid | 1992 |